Glazer Capital LLC’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$10K Hold
2022
Q3
$10K Hold
2022
Q2
$10K Hold
2022
Q1
$10K Buy
2021
Q4
Sell
2021
Q3
$2.11M Sell
2021
Q2
$2.27M Sell
2021
Q1
$3.46M Buy